ACADIA PHARMACEUTICALS INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $540.9M | $147.4M |
| FY2022 | — | $400.4M | $114.8M |
| FY2023 | — | $431.8M | $188.7M |
| FY2024 | — | $732.8M | $319.6M |
| FY2025 | — | $1.23B | $177.7M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $540.9M | $147.4M |
| FY2022 | — | $400.4M | $114.8M |
| FY2023 | — | $431.8M | $188.7M |
| FY2024 | — | $732.8M | $319.6M |
| FY2025 | — | $1.23B | $177.7M |